Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more
Open Access

Fungal virulence studies come of age

Genome Biology20012:reviews1009.1

https://doi.org/10.1186/gb-2001-2-3-reviews1009

Published: 5 March 2001

Abstract

Sophisticated molecular biological research has revealed many virulence attributes in at least four pathogenic fungi, but the future study of fungal virulence requires investigators to distinguish between molecules that directly interact with the host, molecules that regulate these, and molecules that are always required for fungal growth and survival, independent of the host.

Molecular studies of virulence in pathogenic fungi reveal a complex interaction between each fungus species and the human host. The fungi that cause invasive disease differ considerably in their inherent pathogenicity, even though few, if any, approach the level of virulence of the best known bacterial and viral pathogens. Coccidioides immitis, Histoplasma capsulatum, Blastomyces dermatitidis, Paracoccidioides brasiliensis and dermatophyte fungi are all capable of infecting healthy, immunologically intact individuals; they cause many new cases of community-acquired infection each year. By contrast, species such as Candida albicans, Aspergillus fumigatus, Rhizopus species and Fusarium species are normally avirulent in healthy people, but can be disseminated to deep tissues and cause fatal infections in patients with suppressed immune function. These infections present with non-specific symptoms, typically fever, and are often difficult to diagnose as a result. The fungus Cryptococcus neoformans straddles the boundary between 'true' and 'opportunistic' virulence, since it is known as a cause of community-acquired infection, even though most instances of cryptococcosis arise in an immunologically compromised host.

Pathogenic fungal species differ in their cell morphologies: most exist as filamentous moulds (with hyphae) in the environment, but the most virulent among them often change to a unicellular (yeast or spherule) form when they invade tissues. By contrast, C. albicans is an endogenous commensal resident in 15-60% of non-symptomatic individuals, is carried predominantly in the yeast form and commonly exhibits yeast-to-hypha transitions concomitantly with tissue infiltration and infection. Almost all of the fungi that cause fatal diseases gain access to the host via the lungs by inhalation of spores, yet Candida species, which account for a high morbidity and mortality in individuals with reduced numbers of neutrophils, become pathogenic only when lowered host defences allow the fungal cells to pass from the gut into the bloodstream. The dermatophytes parasitize epidermal skin, particularly in sites such as the groin and toe webs, which always tend to be moist, and cause long-standing but non-fatal infections at these sites.

The diversity of pathogenic potency, cellular form and route of invasion between fungal species makes it impossible to draw general conclusions about their molecular virulence attributes. In the case of opportunistic fungal pathogens, an understanding of host immune dysfunction is as important as an appreciation of which fungal genes may encode definable attributes of virulence. Perception of the high incidence of fungal diseases, particularly those that threaten life, has led to considerable investment in research into fungal virulence, often based on cutting-edge molecular biological approaches. But the rapid progress made in identifying molecular virulence factors in several fungal pathogens has also raised some caveats and paradoxes that require resolution.

Fungal virulence factors identified by molecular biology

H. capsulatum var. capsulatum is a dimorphic fungus whose conidia (spores) are inhaled, germinate in the lungs and convert to a budding yeast form that, uniquely among fungal pathogens, becomes an intracellular parasite that is ingested by pulmonary macrophages but survives and multiplies within phagolysosomes. In order to identify factors that contribute to survival within macrophages, Maresca's group [1] used differential-display reverse-transcriptase-coupled PCR to find genes that were specifically up- or down-regulated during the first hour of the interaction between H. capsulatum and macrophages in vitro. They detected five mRNAs with increased expression and one with decreased expression in this time period. Only one of these sequences showed similarity to known genes in the databases: it was a homolog of 100-105 kDa transcriptional co-activator proteins in the rat, human and Caenorhabditis elegans genomes.

Goldman and colleagues [2] recently showed that a 7.8 kDa calcium-binding protein, secreted only by H. capsulatum yeast forms, plays an essential role in ensuring survival of the fungus within macrophages. Disruption of the CBP1 gene, which encodes this protein, resulted in a mutant strain that was unable to destroy a macrophage-like cell line in vitro and showed significantly attenuated virulence in a mouse model of infection [2]. This study also introduced a novel approach to specific gene disruption in H. capsulatum, based on using the URA5 gene as a selectable marker, even though the product of the URA5 gene is itself essential for intracellular survival and virulence in this fungus [3]. In order to demonstrate the virulence role of the H. capsulatum calcium-binding protein (CBP1), therefore, uracil prototrophy had to be restored in the parental strain (by transformation with a ura+ plasmid) before it could be used as a control in the animal experiments [2]. These experiments highlight the need to distinguish between essential metabolic functions in a fungus, and virulence factors that interact directly with mammalian host cells. The first may be essential for virulence; the second are truly 'virulence factors'. Indeed, Retallack et al. [4] have made use of the avirulence of ura5 auxotrophs to establish in vivo expression technology (IVET) for screening other putative H. capsulatum virulence genes.

A similar situation exists in virulence factor research of the opportunist fungus C. albicans. Gene disruption in this organism is complicated by its state of permanent diploidy. Almost all investigators of its putative virulence factors have used disruption cassettes based on URA3 or HIS1 as selectable markers in the absence of other positive selectable markers [5]. Since 1991, at least 40 genes have been identified whose disruption leads to attenuated virulence of the mutant strain when injected intravenously into mice. These genes encode products which range from secreted hydrolytic enzymes through cell-wall polysaccharides and peptides to signal transduction pathway components. C. albicans ura3 strains are themselves less mouse-virulent than uracil-prototrophic strains, however [6,7], as are many other auxotrophic strains [8]. Although auxotrophic mutations affect the virulence of C. albicans, they cannot be described as true virulence factors.

Whereas H. capsulatum survives within macrophages after phagocytic ingestion (and is non-capsulate, despite its name), the capsulate yeast Cryptococcus neoformans resists phagocytic ingestion in the first place. The initial route of infection with C. neoformans, as with H. capsulatum, is mainly by inhalation of the fungus. C. neoformans is disseminated via the bloodstream, however, which usually results in infection of the meninges and brain, with less involvement of other deep tissues. Formation of a capsule and the production of melanin by means of a phenol oxidase enzyme system have long been recognized as essential virulence attributes in C. neoformans, and recent studies have begun to identify individual genes that code for capsule production. Capsule formation serves not only to provide the fungus with a capacity to avoid phagocytosis; it also leads to suppression of cell-mediated and humoral immune responses to the fungus [9]. Gene disruption and complementation studies have shown that at least two genes involved in capsule synthesis, CAP10 [10] and CAP64 [11], are essential for virulence. Considerable research, but not yet at the genomic level, has suggested a role for cryptococcal melanin in protection against host antimicrobial peptides [12].

Gene regulation and virulence

Both melanin production and capsule formation in C. neoformans appear to be regulated by a homolog of the Saccharomyces cerevisiae STE12 gene [13]. STE12 plays a critical role in mating processes in S. cerevisiae, but Chang et al. [13] consider its role in C. neoformans mating regulation as less important than its control of expression of other genes, including those that code for the capsule and for melanin production. Chang and colleagues [13] deserve credit for showing not only that STE12 is required for virulence in mice, but also that this gene probably regulates other virulence factor genes. They did not simply claim STE12 itself as a virulence factor. The C. albicans STE12 homolog, CPH1, does not appear to affect virulence in this fungus [14]. A number of regulatory genes have been shown to be required for full virulence of C. albicans, however, including CEK1, which encodes a MAP kinase [14], CST20 and CLA4, which are related to the STE20-encoded protein kinase [15,16], and HOG1, which also encodes a MAP kinase [17]. Most of these genes are also known to influence the ability of C. albicans yeast cells to form hyphal outshoots, but their influence upon other molecular virulence factors has not yet been examined. Whether it is legitimate to refer to a gene as a virulence determinant when its function is to regulate the expression of host-interactive virulence molecules is an open question. It is likely that most genes involved in central metabolic pathways may be essential for normal growth in vitro and also in vivo. Mutants with defects in these genes are likely to be attenuated in virulence, but their inclusion as potential virulence factors seems to be stretching the point. In this respect it may be more useful to consider virulence factors as those genes in which a mutation affects growth only in vivo. The C. albicans FTR1 gene, which encodes a high-affinity iron permease, however, is required for growth in the iron-limiting conditions of the bloodstream and can reasonably be termed a virulence determinant [18].

Virulence phenotypes and the choice of animal model

In all three of the fungal pathogens discussed so far, attenuation of mouse lethality in mutant fungal strains has been the most common approach to elucidating the roles of specific genes in virulence. It is clear, however, that expression of virulence by a fungus can depend on the particular host niche that is being affected. It is therefore possible to miss virulence factors when only one model for virulence is tested. In C. albicans, disruption of the PHR1 (pH-responsive) gene led to attenuated lethality when injected intravenously into mice, whereas disruption of the related PHR2 gene had no effect on lethality. Conversely, in a rat vaginal Candida infection model, the phr2 mutant was attenuated while the phr1 mutant showed normal virulence [19]. Similarly, in C. neoformans, a mutant with a disrupted URE1 urease gene showed normal virulence when injected intracisternally into rabbits, but showed attenuated lethality in a mouse infected intravenously [20]. Extensive studies of the family of secreted proteinase enzymes (SAP gene products) in C. albicans has also indicated differential expression of the individual SAP genes according to the stage and type of infection under investigation [21]. Clearly, there is no substitute for thorough investigation of virulence phenotypes in as many models of infection as possible in vivo and ex vivo, particularly when single-gene disruptants are under scrutiny, if the true role of virulence molecules in the infection process is to be fully determined.

Fungal virulence and the gene-for-gene hypothesis

A. fumigatus is an opportunistic pathogen of the lungs of severely immunocompromised hosts that can sometimes cause disseminated disease. So far, it is the only pathogenic fungus to have been scrutinized for virulence factors by means of signature-tagged and directed mutagenesis [22]. Holden's group [22] created a pool of mutant fungal strains by insertional mutagenesis with recombinogenic DNA molecules, each marked with a unique oligonucleotide sequence. A mixture of up to 96 mutants was injected into an animal host, and mutants disrupted in a gene essential for survival in vivo were then identified by their absence among fungi recovered from infected tissues. This approach led to the finding that the gene encoding para-aminobenzoic acid synthetase (pabaA) was required for virulence, and that targeted deletion of this gene produced an avirulent variant. Targeted gene disruption experiments revealed that many macromolecules that are thought to serve as virulence factors in other fungi, such as secreted hydrolases, do not contribute significantly to the virulence of A. fumigatus [23]. Only the production of blue-green pigment in the fungal conidia has emerged as a convincing virulence factor in this fungus [23,24]. In this study, disruption of the alb1 gene led both to virulence attenuation and to an immune response in the form of increased complement binding and neutrophil-mediated phagocytosis. Hence the mutation led to increased recognition of the conidia by the immune system.

In plant pathology, the relationship between recognition phenomena and pathogenesis is somewhat contrary to that in medical mycology. In the 'gene-for-gene' model established for plant-pathogen interactions, the loss or mutation of avirulence genes in the fungus leads to escape of pathogen-recognition mechanisms and hence the onset of disease [25]. Hence, mutants can be expected for which virulence is increased. So far, such mutations have not been reported in fungi pathogenic for humans, but we would do well to consider the gene-for gene model should hypervirulent mutations be revealed in future mutagenesis screens.

Studies of virulence at the molecular level have now revealed many factors that contribute to the overall pathogenicity of different fungal types. The only common theme linking the virulence attributes of the four fungi discussed in this review is that no fungus depends upon any single molecule for its virulence. Fungal virulence is a polyvalent, complex process that requires the expression of multiple genes at different stages and different sites of infection. It is important, in future research, that investigators become increasingly self critical. They need to make a clear distinction between those molecules that serve a purely 'housekeeping' function that is equally essential for the fungus in vitro and in vivo, those that are expressed uniquely in infected tissues and interact directly with the host, and those that regulate the expression of host-interactive virulence molecules. More widespread application of approaches such as IVET, transcript profiling of fungi in vivo, differential gene display and signature-tagged mutagenesis are likely to facilitate understanding of fungal virulence at the molecular level.

Authors’ Affiliations

(1)
Department of Molecular and Cell Biology, University of Aberdeen, Institute of Medical Sciences

References

  1. Colonna-Romano S, Porta A, Franco A, Kobayashi GS, Maresca B: Identification and isolation by DDRT-PCR of genes differentially expressed by Histoplasma capsulatum during macrophages infection. Microb Pathog. 1998, 25: 55-66. 10.1006/mpat.1998.0209.PubMedView ArticleGoogle Scholar
  2. Sebghati TS, Engle JT, Goldman WE: Intracellular parasitism by Histoplasma capsulatum: fungal virulence and calcium dependence. Science. 2000, 290: 1368-1372. 10.1126/science.290.5495.1368.PubMedView ArticleGoogle Scholar
  3. Retallack DM, Heinecke EL, Gibbons R, Deepe GS, Woods JP: The URA5 gene is necessary for Histoplasma capsulatum growth during infection of mouse and human cells. Infect Immun. 1999, 67: 624-629.PubMedPubMed CentralGoogle Scholar
  4. Retallack DM, Deepe GS, Woods JP: Applying in vivo expression technology (IVET) to the fungal pathogen Histoplasma capsulatum. Microb Pathog. 2000, 28: 169-182. 10.1006/mpat.1999.0337.PubMedView ArticleGoogle Scholar
  5. Fonzi W, Irwin M: Isogenic strain construction and gene mapping in Candida albicans. Genetics. 1993, 134: 717-728.PubMedPubMed CentralGoogle Scholar
  6. Kirsch DR, Whitney RR: Pathogenicity of Candida albicans auxotrophic mutants in experimental infections. Infect Immun. 1991, 59: 3297-3300.PubMedPubMed CentralGoogle Scholar
  7. Lay J, Henry LK, Clifford J, Koltin Y, Bulawa CE, Becker JM: Altered expression of selectable marker ura3 in gene-disrupted Candida albicans strains complicates interpretation of virulence studies. Infect Immun. 1998, 66: 5301-5306.PubMedPubMed CentralGoogle Scholar
  8. Odds FC: Candida species and virulence. ASM News. 1994, 60: 313-318.Google Scholar
  9. Hamilton AJ: Virulence factors of Cryptococcus neoformans. Curr Top Med Mycol. 1996, 7: 19-42.PubMedGoogle Scholar
  10. Chang YC, Kwon-Chung KJ: Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans. J Bacteriol. 1999, 181: 5636-5643.PubMedPubMed CentralGoogle Scholar
  11. Chang YC, Penoyer LA, Kwon-Chung KJ: The second capsule gene of Cryptococcus neoformans, cap64, is essential for virulence. Infect Immun. 1996, 64: 1977-1983.PubMedPubMed CentralGoogle Scholar
  12. Doering TL, Nosanchuk JD, Roberts WK, Casadevall A: Melanin as a potential cryptococcal defence against microbicidal proteins. Med Mycol. 1999, 37: 175-181. 10.1046/j.1365-280X.1999.00218.x.PubMedView ArticleGoogle Scholar
  13. Chang YC, Wickes BL, Miller GF, Penoyer LA, Kwon Chung KJ: Cryptococcus neoformans STE12 α regulates virulence but is not essential for mating. J Exp Med. 2000, 191: 871-881. 10.1084/jem.191.5.871.PubMedPubMed CentralView ArticleGoogle Scholar
  14. Csank C, Schroppel K, Leberer E, Harcus D, Mohamed O, Meloche S, Thomas DY, Whiteway M: Roles of the Candida albicans mitogen-activated protein kinase homolog, cek1p, in hyphal development and systemic candidiasis. Infect Immun. 1998, 66: 2713-2721.PubMedPubMed CentralGoogle Scholar
  15. Leberer E, Harcus D, Broadbent ID, Clark KL, Dignard D, Ziegelbauer K, Schmidt A, Gow NA, Brown AJ, Thomas DY: Signal transduction through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal formation in the pathogenic fungus Candida albicans. Proc Natl Acad Sci USA. 1996, 93: 13217-13222. 10.1073/pnas.93.23.13217.PubMedPubMed CentralView ArticleGoogle Scholar
  16. Leberer E, Ziegelbauer K, Schmidt A, Harcus D, Dignard D, Ash J, Johnson L, Thomas DY: Virulence and hyphal formation of Candida albicans require the ste20p-like protein kinase cacla4p. Curr Biol. 1997, 7: 539-546.PubMedView ArticleGoogle Scholar
  17. Alonso-Monge R, Navarro-Garcia F, Molero G, Diez-Orejas R, Gustin M, Pla J, Sanchez M, Nombela C: Role of the mitogen-activated protein kinase hog1p in morphogenesis and virulence of Candida albicans. J Bacteriol. 1999, 181: 3058-3068.PubMedPubMed CentralGoogle Scholar
  18. Ramanan N, Wang Y: A high-affinity iron permease essential for Candida albicans virulence. Science. 2000, 288: 1062-1064. 10.1126/science.288.5468.1062.PubMedView ArticleGoogle Scholar
  19. De Bernardis F, Muhlschlegel FA, Cassone A, Fonzi WA: The pH of the host niche controls gene expression in and virulence of Candida albicans. Infect Immun. 1998, 66: 3317-3325.PubMedPubMed CentralGoogle Scholar
  20. Cox GM, Mukherjee J, Cole GT, Casadevall A, Perfect JR: Urease as a virulence factor in experimental cryptococcosis. Infect Immun. 2000, 68: 443-448. 10.1128/IAI.68.2.443-448.2000.PubMedPubMed CentralView ArticleGoogle Scholar
  21. Schaller M, Schackert C, Korting HC, Januschke E, Hube B: Invasion of Candida albicans correlates with expression of secreted aspartic proteinases during experimental infection of human epidermis. J Invest Dermatol. 2000, 114: 712-717. 10.1046/j.1523-1747.2000.00935.x.PubMedView ArticleGoogle Scholar
  22. Brown JS, Aufauvre-Brown A, Brown J, Jennings JM, Arst H, Holden DW: Signature-tagged and directed mutagenesis identify PABA synthetase as essential for Aspergillus fumigatus pathogenicity. Mol Microbiol. 2000, 36: 1371-1380. 10.1046/j.1365-2958.2000.01953.x.PubMedView ArticleGoogle Scholar
  23. Latge JP: Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 1999, 12: 310-350.PubMedPubMed CentralGoogle Scholar
  24. Tsai HF, Chang YC, Washburn RG, Wheeler MH, Kwon Chung KJ: The developmentally regulated alb1 gene of Aspergillus fumigatus - its role in modulation of conidial morphology and virulence. J Bacteriol. 1998, 180: 3031-3038.PubMedPubMed CentralGoogle Scholar
  25. de Wit PMGM: Molecular characterization of gene-for-gene systems in plant-fungus interactions and the application of avirulence genes in control of plant pathogens. Ann Rev Phytopathol. 1992, 30: 391-418. 10.1146/annurev.py.30.090192.002135.View ArticleGoogle Scholar

Copyright

© BioMed Central Ltd 2001

Advertisement